[Management of neuropathic bladder in multiple sclerosis]. / Management della vescica neurologica nella sclerosi multipla.
Clin Ter
; 155(5): 183-6, 2004 May.
Article
en It
| MEDLINE
| ID: mdl-15344566
It is estimated that almost 70% of patients affected by multiple sclerosis (MS) suffer from urinary symptoms, with devastant impact on Quality of Life (QoL). The major aims of management should be to ameliorate the patients quality of life and to prevent the frequent complications of bladder dysfunction such as infention and renal damage. Therapy can usually eliminate or reduce the symptoms of neuropathic bladder. In the following pages is discussed the complex management of urinary symptoms in MS patients.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fenilpropanolamina
/
Vejiga Urinaria Neurogénica
/
Esclerosis Múltiple
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Aspecto:
Patient_preference
Límite:
Humans
Idioma:
It
Revista:
Clin Ter
Año:
2004
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Italia